Symic Bio Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
2
- Latest Deal Type
-
2ndary - Private
- Investors
-
14
Symic Bio General Information
Description
Developer of a matrix regulator therapeutics technology designed to affect matrix degradation and structure. The company's technology offers therapeutics that bind to targets in the matrix, damage in response to injury or because of disease, and inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology, and diseases of the central nervous system.
Contact Information
Website
www.symic.bioCorporate Office
- 1400 Pine Street
- Suite 640505
- San Francisco, CA 94164
- United States
Corporate Office
- 1400 Pine Street
- Suite 640505
- San Francisco, CA 94164
- United States
Symic Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 8. Secondary Transaction - Private | 17-Nov-2021 | Completed | Clinical Trials - Phase 2 | |||
| 7. Later Stage VC | 26-Apr-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Later Stage VC (Series B) | 22-May-2017 | Completed | Clinical Trials - Phase 2 | |||
| 5. Early Stage VC (Series A2) | 01-Dec-2015 | Completed | Startup | |||
| 4. Grant | 26-Aug-2015 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 07-Aug-2015 | Completed | Startup | |||
| 2. Early Stage VC | 21-Nov-2013 | $1.5M | $1.5M | Completed | Startup | |
| 1. Accelerator/Incubator | Completed | Startup |
Symic Bio Comparisons
Industry
Financing
Details
Symic Bio Competitors (9)
One of Symic Bio’s 9 competitors is Ona Therapeutics, a Venture Capital-Backed company based in Barcelona, Spain.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain | ||||
| Volastra | Venture Capital-Backed | New York, NY | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ |
Symic Bio Signals
Symic Bio Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| SBI Shinsei Bank | Corporation | Minority | ||
| Alexandria Venture Investments | Venture Capital | Minority | ||
| Heda Ventures | Venture Capital | Minority | ||
| Nordic Bioscience | Corporation | Minority | ||
| National Institute of Diabetes and Digestive and Kidney Diseases | Government |
Symic Bio FAQs
-
When was Symic Bio founded?
Symic Bio was founded in 2012.
-
Where is Symic Bio headquartered?
Symic Bio is headquartered in San Francisco, CA.
-
What is the size of Symic Bio?
Symic Bio has 2 total employees.
-
What industry is Symic Bio in?
Symic Bio’s primary industry is Drug Discovery.
-
Is Symic Bio a private or public company?
Symic Bio is a Private company.
-
What is Symic Bio’s current revenue?
The current revenue for Symic Bio is .
-
How much funding has Symic Bio raised over time?
Symic Bio has raised $84.1M.
-
Who are Symic Bio’s investors?
SBI Shinsei Bank, Alexandria Venture Investments, Heda Ventures, Nordic Bioscience, and National Institute of Diabetes and Digestive and Kidney Diseases are 5 of 14 investors who have invested in Symic Bio.
-
Who are Symic Bio’s competitors?
Ona Therapeutics, Volastra, Avalyn Pharma, Ability Pharma, and Bristol-Myers Squibb are some of the 9 competitors of Symic Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process